Acute Ischemic Stroke Risk Higher With COVID-19 Than Influenza
Higher risk remains even when adjusting for demographic and clinical features.
COVID19
Endotheliopathy ID’d in COVID-19, Tied to Higher Mortality Risk
Soluble thrombomodulin concentration >3.26 ng/mL linked to lower rates of hospital discharge, survival.
Study to Assess Antiviral Antibody Cocktail for COVID-19 Prevention Begins
A phase 3 trial evaluating an investigational antiviral antibody cocktail, REGN-COV2, for the prevention of COVID-19 has been initiated by Regeneron Pharmaceuticals.
A Closer Look at Ischemic Stroke and COVID-19 in a New York Healthcare System
Researchers sought to identify and characterize stroke in COVID-19 in a single healthcare system in New York.
FDA: Risk of Methanol Toxicity With Certain Hand Sanitizers
Hand sanitizers containing methanol, or wood alcohol, present a danger to individuals as the substance can be toxic when absorbed through the skin or life-threatening if ingested.
Siltuximab to Be Evaluated for COVID-19 Associated ARDS in Phase 3 Trial
Siltuximab is currently marketed under the trade name Sylvant and is indicated for the treatment of multicentric Castleman’s disease.
Immunotherapy May Increase Risk for Hospitalization, Severe Respiratory Illness From COVID-19
Patients with cancer and COVID-19 had high rates of hospitalization and/or respiratory illness, particularly among those taking immunotherapy or those older than 65 years.
Limited ESA Use in COVID-19 Patients Recommended
Infection with the virus that causes COVID-19, coupled with use of erythropoiesis-stimulating agents may result in additive prothrombotic effects, according to the authors.
Heart Rhythm Disorders Seen in Critically Ill COVID-19 Patients
ICU admission tied to incident atrial fibrillation, nonsustained ventricular tachycardias.
COVID-19 Vaccine Candidate Looks Promising in Early Human Trial
Pfizer and BioNTech SE announced positive preliminary results from the phase 1/2 study evaluating the safety, tolerability, and immunogenicity of escalating doses of the vaccine candidate BNT162b1 against COVID-19.
-
Loading...
-
Loading...
Next post in Men's Health Update
